Growing applications from other end-use industry such as plywood production, cattle feed, cosmetics,paints etc., are projected to drive the global anti-infective agents market growth over the forecast period. The global anti-infective agents market size expected to reach at nearly USD 144.9 billion by 2026. The global anti-infective agents market is likely to expand at a CAGR of more than 3.6% from 2018 to 2026.
The global anti-infective agents market is segmented into type, route of administration, distribution channel, and region. On the basis of type, the global market is segmented into antibacterials, antivirals, and antifungals. Furthermore, the antibacterials segment includes cephalosporins, penicillin, fluoroquinolones, macrolides, carbapenem, and others; and the antivirals segment includes azoles, echinocandins, polyenes, and others. On the basis of route of administration, the global market is segmented into topical, oral, IV, and others. On the basis of distribution channel, the global market is segmented into hospital pharmacies, retail pharmacies, specialty pharmacies, e-commerce, and others. On the basis of geography, the global market is segment into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.
Market Segmentation by Type:
Market Segmentation by Route of Administration:
Market Segmentation by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Specialty Pharmacies
Market Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
North America market was one of the main local markets regarding income in 2018. High pervasiveness of irresistible maladies incorporating clinic obtained contaminations in both, kids and grown-ups, and the resultant abuse of antibiotics combined with expanded availability of non-solution anti-infectives are the real drivers. The Asia Pacific is one of the quickest developing territorial market attributable to the nearness of high, neglected interest for novel medications, fast upgrades in medicinal services foundation combined with bringing issues to light among social insurance experts and patients.
Major companies contributing the global anti-infective agents market are Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi.